Faculty
Oncology Division
Alphabetical list (active faculty):   
Kiran R. Vij

Kiran R. Vij, MD

Associate Professor

Department of Medicine

Oncology Division

Bone Marrow Transplantation & Leukemia

Department of Pathology & Immunology

Clinical Interests

  • Hematopathology

Contact

  • 314-454-7425 (office)
  • 314-454-7551 (fax)
  • Division of Oncology
    Campus Box 8056
    Washington University
    660 South Euclid Avenue
    St. Louis, MO 63110
  • 11th Floor Mid-Campus Center (office)

Original Articles

  • Phospho-Ser(784)-VCP Drives Resistance of Pancreatic Ductal Adenocarcinoma to Genotoxic Chemotherapies and Predicts the Chemo-Sensitizing Effect of VCP Inhibitor
    Wang F, Vij K, Li L, Dodhiawala P, Lim KH, Shao J
    Cancers (Basel) 2021 Oct 11;13(20):13205076
  • Baricitinib Prevents GvHD by Increasing Tregs Via JAK3 and Treats Established GvHD by Promoting Intestinal Tissue Repair Via EGFR
    Kim S, Ashami K, Lim S, Staser K, Vij K, Santhanam S, Ritchey J, Peterson S, Gao F, Ciorba MA, Cooper ML, DiPersio JF, Choi J
    Leukemia 2021 Jul 24; [Epub ahead of print]
  • Selective Targeting of Alpha4beta1 Integrin Attenuates Murine Graft Versus Host Disease
    Alahmari B, Cooper ML, Vij K, Ritchey J, Ruminski P, Gao F, Choi J, DiPersio JF
    Leukemia 2020 Nov;34(11):3100-3104
  • Phospho-Ser(784)-VCP Is Required for DNA Damage Response and Is Associated With Poor Prognosis of Chemotherapy-Treated Breast Cancer
    Zhu C, Rogers A, Asleh K, Won J, Gao D, Leung S, Li S, Vij KR, Zhu J, Held JM, You Z, Nielsen TO, Shao J
    Cell Rep 2020 Jun 9;31(10):107745
  • Resolution of Secondary Hemophagocytic Lymphohistiocytosis After Treatment With the JAK1/2 Inhibitor Ruxolitinib
    Goldsmith SR, Saif Ur Rehman S, Shirai CL, Vij KR, DiPersio JF
    Blood Adv 2019 Dec 10;3(23):4131-4135
  • Practical Approaches on CD30 Detection and Reporting in Lymphoma Diagnosis
    Xu ML, Gabali A, Hsi ED, Fedoriw Y, Vij K, Salama ME, Ramchandren R, O'Malley D, Wick MR, Battistella M, Gru AA
    Am J Surg Pathol 2020 Feb;44(2):e1-e14
  • Reactivity With the EpCAM-Specific Antibodies MOC-31 and Ber-Ep4 in Plasma Cell Neoplasms: A Potential Diagnostic Pitfall in Cytology Samples
    Weimholt RC, Sharifai N, Abro B, Vij K, Bernadt C
    J Am Soc Cytopathol 2019 Sep-Oct;8(5):265-269
  • Prognostic Value of Prior Consolidation in Acute Myeloid Leukemia Patients Undergoing Hematopoietic Cell Transplantation in Minimal Residual Disease-Negative First Complete Remission
    How J, Vij KR, Ebadi M, DeFor TE, Romee R, Dolan MM, Ustun C, Weisdorf DJ, Linden MA, Rashidi A
    Am J Hematol 2018 Dec;93(12):E381-E383
  • Baricitinib-Induced Blockade of Interferon Gamma Receptor and Interleukin-6 Receptor for the Prevention and Treatment of Graft-Versus-Host Disease
    Choi J, Cooper ML, Staser K, Ashami K, Vij KR, Wang B, Marsala L, Niswonger J, Ritchey J, Alahmari B, Achilefu S, Tsunoda I, Schroeder MA, DiPersio JF
    Leukemia 2018 Nov;32(11):2483-2494
  • Lenalidomide Results in a Durable Complete Remission in Acute Myeloid Leukemia Accompanied by Persistence of Somatic Mutations and a T-Cell Infiltrate in the Bone Marrow
    Bansal D, Vij K, Chang GS, Miller CA, DiPersio JF, Vij R, Heath SE, Westervelt P, Welch JS, Fehniger TA
    Haematologica 2018 Jun;103(6):e270-e273
  • Serum Thymidine Kinase 1 Activity as a Pharmacodynamic Marker of Cyclin-Dependent Kinase 4/6 Inhibition in Patients With Early-Stage Breast Cancer Receiving Neoadjuvant Palbociclib
    Bagegni N, Thomas S, Liu N, Luo J, Hoog J, Northfelt DW, Goetz MP, Forero A, Bergqvist M, Karen J, Neumuller M, Suh EM, Guo Z, Vij K, Sanati S, Ellis M, Ma CX
    Breast Cancer Res 2017 Nov 21;19(1):123
  • HTLV-1 Viral Oncogene HBZ Induces Osteolytic Bone Disease in Transgenic Mice
    Esser AK, Rauch DA, Xiang J, Harding JC, Kohart NA, Ross MH, Su X, Wu K, Huey D, Xu Y, Vij K, Green PL, Rosol TJ, Niewiesk S, Ratner L, Weilbaecher KN
    Oncotarget 2017 Aug 27;8(41):69250-69263
  • A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, With Anastrozole in Clinical Stage II or III PIK3CA-Mutant ER-Positive and HER2-Negative Breast Cancer
    Ma CX, Suman V, Goetz MP, Northfelt D, Burkard ME, Ademuyiwa F, Naughton M, Margenthaler J, Aft R, Gray R, Tevaarwerk A, Wilke L, Haddad T, Moynihan T, Loprinzi C, Hieken T, Barnell EK, Skidmore ZL, Feng YY, Krysiak K, Hoog J, Guo Z, Nehring L, Wisinski KB, Mardis E, Hagemann IS, Vij K, Sanati S, Al-Kateb H, Griffith OL, Griffith M, Doyle L, Erlichman C, Ellis MJ
    Clin Cancer Res 2017 Nov 15;23(22):6823-6832
  • Allogeneic Hematopoietic Cell Transplantation in Morphologic Leukemia-Free Aplastic State
    Rashidi A, Ali AM, Vij KR, Shanley R, Romee R, Cooley SA, Westervelt P, DiPersio JF, Miller JS, Weisdorf DJ, Ustun C
    Am J Hematol 2017 Sep;92(9):E549-E552
  • Azacitidine Mitigates Graft-Versus-Host Disease Via Differential Effects on the Proliferation of T Effectors and Natural Regulatory T Cells in Vivo
    Cooper ML, Choi J, Karpova D, Vij K, Ritchey J, Schroeder MA, DiPersio JF
    J Immunol 2017 May 1;198(9):3746-3754
  • NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer
    Ma CX, Gao F, Luo J, Northfelt DW, Goetz M, Forero A, Hoog J, Naughton M, Ademuyiwa F, Suresh R, Anderson KS, Margenthaler J, Aft R, Hobday T, Moynihan T, Gillanders W, Cyr A, Eberlein TJ, Hieken T, Krontiras H, Guo Z, Lee MV, Spies NC, Skidmore ZL, Griffith OL, Griffith M, Thomas S, Bumb C, Vij K, Bartlett CH, Koehler M, Al-Kateb H, Sanati S, Ellis MJ
    Clin Cancer Res 2017 Aug 1;23(15):4055-4065
  • Tissue Polymerase Chain Reaction for the Diagnosis of Cytomegalovirus Disease After Allogeneic Hematopoietic Cell Transplantation
    Rashidi A, Vij KR, Buller RS, Wylie KM, Storch GA, DiPersio JF
    Am J Hematol 2017 Feb;92(2):E19-E20
  • Targeted Sequencing Informs the Evaluation of Normal Karyotype Cytopenic Patients for Low-Grade Myelodysplastic Syndrome
    Duncavage EJ, O'Brien J, Vij K, Miller CA, Chang GS, Shao J, Jacoby MA, Heath S, Janke MR, Elliott K, Fulton RS, Fronick C, O'Laughlin M, Westervelt P, Ley TJ, Wilson RK, Walter MJ
    Leukemia 2016 Dec;30(12):2422-2426
  • Aberrant Expression of Alpha-Fetoprotein in Intrahepatic Cholangiocarcinoma: An Exceptional Occurrence
    Vij K, Wang HL
    Int J Surg Pathol 2008 Apr;16(2):194-8
  • Mice Expressing a Dominant-Negative Ret Mutation Phenocopy Human Hirschsprung Disease and Delineate a Direct Role of Ret in Spermatogenesis
    Jain S, Naughton CK, Yang M, Strickland A, Vij K, Encinas M, Golden J, Gupta A, Heuckeroth R, Johnson EM Jr, Milbrandt J
    Development 2004 Nov;131(21):5503-13
  • Causes of Abnormal Uterine Bleeding
    Vij K
    Doctoral Thesis 1999

Book Chapters

  • Testis and Paratestis
    Vij K, Humphrey PA
    In: The Washington Manual of Surgical Pathology, 2nd Edition, 2012; pp 451-6
  • Testis and Paratestis
    Vij K, Humphrey PA
    In: The Washington Manual of Surgical Pathology, 1st Edition, 2008; pp 361-4